NOVARTIS-CLAF237A2301

Study Sponsor: Novartis

Study Title

A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes

Medicine or Vaccine (generic name)

vildagliptin

Sponsor Identification Number

CLAF237A2301

Trial Registry Identification Number(#'s)

NCT00099905

Medical Condition

Diabetes Mellitus, Type 2

Phase

Phase 3

Link to study details on the Novartis Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

July 2023